Kidney stones (renal calculi) are one of the most painful conditions a person can experience — and one of the most common urological conditions in South Africa. The combination of a hot climate, high dietary salt and purine intake, and dehydration makes SA a relatively high-incidence country for urolithiasis. From a medical aid perspective, acute kidney stone treatment is PMB-covered; recurrent stone prevention is day-to-day; and the stone removal procedures themselves can involve significant specialist shortfalls.
What Are Kidney Stones?
Kidney stones form when minerals and salts in the urine become supersaturated and crystallise in the kidney. The stones may remain in the kidney asymptomatically for years, or they may pass into the ureter — causing the classic severe, colicky flank pain radiating to the groin.
Stone types in SA: - Calcium oxalate (70–80%): Most common. Risk factors: low fluid intake, high-oxalate diet, hypercalciuria. - Uric acid stones (10–15%): Associated with gout, high purine diet (meat, beer), low urine pH. Radiolucent on X-ray — only visible on CT. - Struvite/infection stones (5–10%): Associated with chronic urinary tract infections (Proteus, Klebsiella); can grow large ("staghorn calculi"). - Calcium phosphate, cystine: Less common.
Symptoms: Classic ureteric colic — sudden severe flank pain radiating to the lower abdomen and groin, often with nausea, vomiting, and inability to find a comfortable position. Blood in urine (haematuria) — visible or microscopic — is common. Fever with ureteric colic = infection proximal to obstruction = urological emergency.
Is Kidney Stone Treatment a PMB Condition?
Yes. Renal calculi (acute urinary calculi) is a PMB Diagnosis and Treatment Pair.
Your scheme must fund: - Emergency assessment and analgesia - Diagnostic imaging (CT KUB — the gold standard) - Hospital admission for pain management or intervention - Stone removal procedures (lithotripsy/ESWL, ureteroscopy, PCNL) when indicated
Recurrent stone prevention (metabolic workup, preventive medication, dietary counselling) is day-to-day.
How Does Medical Aid Cover Kidney Stones?
| Service | PMB? | Typical cover | Notes |
|---|---|---|---|
| Emergency ER assessment | Yes — PMB | Hospital benefit | |
| CT KUB (CT of kidneys, ureter, bladder) | Yes — PMB (acute) | Radiology/hospital benefit | Gold standard for stone diagnosis |
| Ultrasound (initial or pregnancy) | Yes — PMB (acute) | Radiology benefit | Inferior to CT but no radiation |
| Blood tests (renal function, urate, calcium) | Yes — PMB (acute) | Pathology benefit | |
| IV analgesia (NSAIDs, opioids) | Yes — PMB (acute) | Hospital/ER benefit | |
| Hospital admission (acute pain, obstruction) | Yes — PMB | Hospital benefit | |
| Tamsulosin (alpha-blocker — facilitates passage of small stones) | No | Day-to-day | R400–R800/month; prescribed while awaiting passage |
| ESWL (extracorporeal shock wave lithotripsy) | Yes — PMB | Hospital/day procedure benefit | Non-invasive; for stones <10–15mm in kidney |
| Ureteroscopy + laser lithotripsy (URS) | Yes — PMB | Hospital benefit | For ureteric stones; requires DSA or theatre |
| Percutaneous nephrolithotomy (PCNL) | Yes — PMB | Hospital benefit | For large or complex stones; requires pre-auth |
| Stent (JJ ureteric stent) | Yes — PMB | Hospital benefit | Often inserted after ureteroscopy; removal is additional procedure |
| JJ stent removal (cystoscopy) | Yes — PMB | Day procedure benefit | Requires separate pre-authorisation |
| 24-hour urine metabolic workup (prevention) | No | Pathology benefit | For recurrent stone formers |
| Potassium citrate (uric acid stone prevention) | No | Day-to-day | R300–R600/month |
| Allopurinol (uric acid stone — if hyperuricaemia present) | No | Day-to-day | Generic: R50–R150/month |
| Hydrochlorothiazide (calcium stone prevention) | No | Day-to-day / CDL if hypertensive | For hypercalciuria |
Stone Removal Procedures — What Happens
Watchful waiting + tamsulosin: Stones <4–5mm in the ureter have a high spontaneous passage rate (70–80%). Tamsulosin (alpha-blocker) relaxes the ureteric muscle and facilitates passage. Pain management while waiting is day-to-day/ER.
ESWL (lithotripsy): Focused shock waves from outside the body fragment the stone into passable pieces. Non-invasive; performed under sedation or analgesia. Day procedure. Effective for kidney stones <15mm in accessible positions. Requires a specific ESWL unit — not all hospitals have this equipment. Pre-authorise with your scheme.
Ureteroscopy (URS): A thin telescope is passed into the ureter/kidney under GA; laser or mechanical fragmentation of the stone. Highly effective for ureteric stones. A JJ stent is often left in situ for 1–2 weeks after the procedure. Stent removal requires a second brief cystoscopy (pre-authorise separately).
PCNL (percutaneous nephrolithotomy): For large stones (>20mm) or staghorn calculi. An instrument is passed directly into the kidney through a small back incision. General anaesthesia; 2–3 day hospital stay. Most complex and effective for large stones.
Day-to-Day Costs: What to Budget For
| Scenario | Estimated cost |
|---|---|
| Single stone — self-passage (tamsulosin + analgesia) | R5,000 – R15,000 |
| Stone requiring ESWL | R15,000 – R35,000 (procedure + analgesia) |
| Stone requiring URS + laser + stent | R25,000 – R60,000 (procedure + stent removal) |
| Large stone requiring PCNL | R50,000 – R120,000 |
| Recurrent stone prevention (metabolic workup + medication) | R8,000 – R20,000/year |
Gap cover: Urologist and anaesthesiologist shortfalls for in-hospital stone removal procedures are significant. Gap cover OPL addresses these.
Recurrence — Why Prevention Matters
50% of first-time stone formers have a recurrence within 10 years. Prevention is far cheaper than repeated procedures.
After a first stone: - 24-hour urine collection (metabolic workup) — pathology benefit - Stone analysis (if stone is retrieved) — send it to pathology; stone type guides prevention - Fluid intake advice: target urine output >2 litres/day - Dietary modification: reduce salt, animal protein; avoid excessive oxalate (spinach, nuts, chocolate) for calcium oxalate formers - Medications (potassium citrate, hydrochlorothiazide, allopurinol) — day-to-day
Key Questions to Ask Your Scheme
- Is ESWL or ureteroscopy pre-authorised, and is the treating urologist on the DSP panel? Some schemes have specific lithotripsy unit contracts.
- Is JJ stent removal (cystoscopy) covered under the same pre-authorisation as the primary procedure? Get written confirmation.
- Is tamsulosin on my formulary for stone passage? It should be.
- Has gap cover been notified of the procedure? Essential before any in-hospital stone intervention.
Talk to Eldon
Kidney stone treatment is PMB-covered but involves significant specialist shortfalls. AURA ensures gap cover is in place and identifies DSP urologists for stone procedures.
See which plans pay for kidney stone management →